Live Chat

New Drug May Be Able to Reverse Xarelto’s Side Effects

Xarelto is one of the newest blood thinners on the market. It is prescribed to treat patients who are at risk of developing blood clots. However, Xarelto has recently received negative feedback from the pharmaceutical world because of its various side effects, the most common and most negative of them being an increased risk of internal bleeding. Patients who have brought civil lawsuits against the manufacturers, Bayer and Johnson & Johnson, allege that they failed to inform the doctors, patients, and the FDA of the serious side effects and issues.

As of the beginning of January, Portola Pharmaceuticals released information of an experimental drug, called andexanet alfa, which may be able to immediately reverse the anticoagulation activity that can occur in patients taking Xarelto. The development of this antidote has the opportunity to provide vital treatment options for patients who experience major bleeding or require emergency surgery. It’s currently in a late-stage study. 

 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

 

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

 

Categories
Drug Litigation